Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Gere Sunder‐Plassmann
Safety of Switching to Migalastat From Enzyme Replacement Therapy in Fabry Disease: Experience From the Phase 3 ATTRACT Study
American Journal of Medical Genetics, Part A
Genetics
Related publications
Renal Aspects and Enzyme Replacement Therapy of Fabry Disease
Effects of Enzyme Replacement Therapy and Antidrug Antibodies in Patients With Fabry Disease
Journal of the American Society of Nephrology : JASN
Medicine
Nephrology
Effects of Enzyme Replacement Therapy in Fabry Disease—A Comprehensive Review of the Medical Literature
Genetics in Medicine
Medicine
Genetics
Efficacy and Safety of Migalastat in a Japanese Population: A Subgroup Analysis of the ATTRACT Study
Clinical and Experimental Nephrology
Physiology
Nephrology
Do We Need More Intensive Enzyme Replacement Therapy for Anderson-Fabry Disease?
Medical Hypotheses
Medicine
Limited Effects of Long-Term Enzyme Replacement Therapy on the Cardiac Conduction System in Fabry Disease
Journal of Cardiology Cases
Cardiovascular Medicine
Cardiology
Gender Differences in the Application of Spanish Criteria for Initiation of Enzyme Replacement Therapy for Fabry Disease in the Fabry Outcome Survey
International Journal of Molecular Sciences
Organic Chemistry
Molecular Biology
Theoretical Chemistry
Inorganic Chemistry
Computer Science Applications
Spectroscopy
Medicine
Catalysis
Physical
Modeling the Effect of Enzyme Replacement Therapy on Life-Threatening Complications in Patients With Fabry Disease
PHARMACOECONOMICS. Modern pharmacoeconomics and pharmacoepidemiology
Prominent Regression of Corneal Deposits in Fabry Disease 16 Years After Initiation of Enzyme Replacement Therapy
Acta Ophthalmologica
Medicine
Ophthalmology